Top compounds associated with response to LRRC37A2


Feature Type Standardized
Nominal ANOVA
mRNA alisertib CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA SKI-II CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA PL-DI CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 9e-05
Download CSV